About the Chronic Lymphocytic Leukemia Session
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, characterized by the excessive production of abnormal lymphocytes, a type of white blood cell. Despite advancements in cancer research, CLL remains challenging due to its heterogeneity and varying progression rates among patients. Recent studies have focused on understanding the genetic and molecular mechanisms underlying CLL, leading to the development of targeted therapies such as BTK inhibitors and monoclonal antibodies. Immunotherapy, particularly chimeric antigen receptor (CAR) T-cell therapy, has also shown promising results in CLL treatment by harnessing the body's immune system to target cancer cells. Ongoing research aims to unravel CLL's complexities further, paving the way for more effective personalized treatment strategies and improved patient outcomes.
Topics Covered in Chronic Lymphocytic Leukemia
BTK Inhibitors
IGHV Mutation Status
Genomic Risk Markers
Fixed-Duration Therapy
Minimal Residual Disease
Lymphoma Transformation
Related Scientific Sessions at CIOC 2027
Why Attend the Chronic Lymphocytic Leukemia Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Chronic Lymphocytic Leukemia work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Chronic Lymphocytic Leukemia research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Chronic Lymphocytic Leukemia track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Chronic Lymphocytic Leukemia Conference 2027 — FAQs
What is the Chronic Lymphocytic Leukemia track at CIOC 2027?
The Chronic Lymphocytic Leukemia track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Chronic Lymphocytic Leukemia. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Chronic Lymphocytic Leukemia sessions?
Cancer researchers and clinicians, educators and students with an interest in Chronic Lymphocytic Leukemia are all welcome — whether presenting or attending.
Can I present my research in the Chronic Lymphocytic Leukemia track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Chronic Lymphocytic Leukemia sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Chronic Lymphocytic Leukemia track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.